(Reuters) - HepaGam B is made from a protein derived from human plasma that can provide immunity to the hepatitis B virus, the Food and Drug Administration said.
Patients must receive injections at the time of liver transplant and throughout their lives, the FDA said.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment